188 related articles for article (PubMed ID: 19707575)
1. The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial.
Carling CL; Kristoffersen DT; Montori VM; Herrin J; Schünemann HJ; Treweek S; Akl EA; Oxman AD
PLoS Med; 2009 Aug; 6(8):e1000134. PubMed ID: 19707575
[TBL] [Abstract][Full Text] [Related]
2. How should the impact of different presentations of treatment effects on patient choice be evaluated? A pilot randomized trial.
Carling C; Kristoffersen DT; Herrin J; Treweek S; Oxman AD; Schünemann H; Akl EA; Montori V
PLoS One; 2008; 3(11):e3693. PubMed ID: 19030110
[TBL] [Abstract][Full Text] [Related]
3. The effect of how outcomes are framed on decisions about whether to take antihypertensive medication: a randomized trial.
Carling CL; Kristoffersen DT; Oxman AD; Flottorp S; Fretheim A; Schünemann HJ; Akl EA; Herrin J; MacKenzie TD; Montori VM
PLoS One; 2010 Mar; 5(3):e9469. PubMed ID: 20209127
[TBL] [Abstract][Full Text] [Related]
4. The effect of alternative graphical displays used to present the benefits of antibiotics for sore throat on decisions about whether to seek treatment: a randomized trial.
Carling CL; Kristoffersen DT; Flottorp S; Fretheim A; Oxman AD; Schünemann HJ; Akl EA; Herrin J; MacKenzie TD; Montori VM
PLoS Med; 2009 Aug; 6(8):e1000140. PubMed ID: 19707579
[TBL] [Abstract][Full Text] [Related]
5. Decision aids for people facing health treatment or screening decisions.
Stacey D; Légaré F; Col NF; Bennett CL; Barry MJ; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L; Wu JH
Cochrane Database Syst Rev; 2014 Jan; (1):CD001431. PubMed ID: 24470076
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
7. The causes and effects of socio-demographic exclusions from clinical trials.
Bartlett C; Doyal L; Ebrahim S; Davey P; Bachmann M; Egger M; Dieppe P
Health Technol Assess; 2005 Oct; 9(38):iii-iv, ix-x, 1-152. PubMed ID: 16181564
[TBL] [Abstract][Full Text] [Related]
8. Helping patients to reach decisions regarding their treatment: Do 'non-directive' approaches cause systematic bias?
MacInnes JA; Salkovskis PM; Wroe A; Hope T
Br J Health Psychol; 2015 Nov; 20(4):877-88. PubMed ID: 26286684
[TBL] [Abstract][Full Text] [Related]
9. Patients prefer pictures to numbers to express cardiovascular benefit from treatment.
Goodyear-Smith F; Arroll B; Chan L; Jackson R; Wells S; Kenealy T
Ann Fam Med; 2008; 6(3):213-7. PubMed ID: 18474883
[TBL] [Abstract][Full Text] [Related]
10. Decision aids for people facing health treatment or screening decisions.
Stacey D; Bennett CL; Barry MJ; Col NF; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Légaré F; Thomson R
Cochrane Database Syst Rev; 2011 Oct; (10):CD001431. PubMed ID: 21975733
[TBL] [Abstract][Full Text] [Related]
11. Presenting risk information to people with diabetes: evaluating effects and preferences for different formats by a web-based randomised controlled trial.
Edwards A; Thomas R; Williams R; Ellner AL; Brown P; Elwyn G
Patient Educ Couns; 2006 Nov; 63(3):336-49. PubMed ID: 16860964
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Baigent C; Keech A; Kearney PM; Blackwell L; Buck G; Pollicino C; Kirby A; Sourjina T; Peto R; Collins R; Simes R;
Lancet; 2005 Oct; 366(9493):1267-78. PubMed ID: 16214597
[TBL] [Abstract][Full Text] [Related]
13. Using quantitative risk information in decisions about statins: a qualitative study in a community setting.
Polak L; Green J
Br J Gen Pract; 2015 Apr; 65(633):e264-9. PubMed ID: 25824187
[TBL] [Abstract][Full Text] [Related]
14. Number of patients needed to prescribe statins in primary cardiovascular prevention: mirage and reality.
Rossignol M; Labrecque M; Cauchon M; Breton MC; Poirier P
Fam Pract; 2018 Jul; 35(4):376-382. PubMed ID: 29267889
[TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering drug therapy in elderly patients.
Berthold HK; Gouni-Berthold I
Curr Pharm Des; 2011; 17(9):877-93. PubMed ID: 21418034
[TBL] [Abstract][Full Text] [Related]
16. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
17. Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs.
Dickinson R; Raynor DK; Knapp P; MacDonald J
BMJ Open; 2016 Dec; 6(12):e012000. PubMed ID: 27913558
[TBL] [Abstract][Full Text] [Related]
18. Decision aids for people facing health treatment or screening decisions.
O'Connor AM; Stacey D; Rovner D; Holmes-Rovner M; Tetroe J; Llewellyn-Thomas H; Entwistle V; Rostom A; Fiset V; Barry M; Jones J
Cochrane Database Syst Rev; 2001; (3):CD001431. PubMed ID: 11686990
[TBL] [Abstract][Full Text] [Related]
19. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
Vrecer M; Turk S; Drinovec J; Mrhar A
Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
[TBL] [Abstract][Full Text] [Related]
20. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.
Weymiller AJ; Montori VM; Jones LA; Gafni A; Guyatt GH; Bryant SC; Christianson TJ; Mullan RJ; Smith SA
Arch Intern Med; 2007 May; 167(10):1076-82. PubMed ID: 17533211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
